These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 23707147)

  • 1. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.
    Diallo A; Jacobi H; Cook A; Labrum R; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sobanska A; Sulek A; Schmitz-Hübsch T; Schöls L; Hengel H; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Boesch S; Pandolfo M; Schulz JB; Bauer P; Giunti P; Kang JS; Klockgether T; Tezenas du Montcel S
    Lancet Neurol; 2018 Apr; 17(4):327-334. PubMed ID: 29553382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
    Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
    Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study.
    Velázquez-Pérez L; Rodríguez-Labrada R; Canales-Ochoa N; Montero JM; Sánchez-Cruz G; Aguilera-Rodríguez R; Almaguer-Mederos LE; Laffita-Mesa JM
    Lancet Neurol; 2014 May; 13(5):482-9. PubMed ID: 24657153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
    Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Sarro L; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Nachbauer W; Kang JS; Pandolfo M; Schulz JB; Melac AT; Diallo A; Klockgether T
    J Neurol; 2018 Sep; 265(9):2040-2051. PubMed ID: 29959555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings.
    Jacobi H; Hauser TK; Giunti P; Globas C; Bauer P; Schmitz-Hübsch T; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdzienicka E; Kang JS; Ratzka S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; Tezenas du Montcel S; Borkert J; Schulz JB; Klockgether T
    Cerebellum; 2012 Mar; 11(1):155-66. PubMed ID: 21701895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease progression of spinocerebellar ataxia types 1, 2, 3 and 6 before and after ataxia onset.
    Jacobi H; Schaprian T; Schmitz-Hübsch T; Schmid M; Klockgether T;
    Ann Clin Transl Neurol; 2023 Oct; 10(10):1833-1843. PubMed ID: 37592453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
    Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M
    Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.
    Ashizawa T; Figueroa KP; Perlman SL; Gomez CM; Wilmot GR; Schmahmann JD; Ying SH; Zesiewicz TA; Paulson HL; Shakkottai VG; Bushara KO; Kuo SH; Geschwind MD; Xia G; Mazzoni P; Krischer JP; Cuthbertson D; Holbert AR; Ferguson JH; Pulst SM; Subramony SH
    Orphanet J Rare Dis; 2013 Nov; 8():177. PubMed ID: 24225362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central auditory processing in patients with spinocerebellar ataxia.
    Zeigelboim BS; de Carvalho HA; Teive HA; Liberalesso PB; Jurkiewicz AL; da Silva Abdulmassih EM; Marques JM; Cordeiro ML
    Hear Res; 2015 Sep; 327():235-44. PubMed ID: 26183435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7.
    Moriarty A; Cook A; Hunt H; Adams ME; Cipolotti L; Giunti P
    Orphanet J Rare Dis; 2016 Jun; 11(1):82. PubMed ID: 27333979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Changes of Clinical, Imaging, and Fluid Biomarkers in Preataxic and Early Ataxic Spinocerebellar Ataxia Type 2 and 7 Carriers.
    Coarelli G; Dubec-Fleury C; Petit E; Sayah S; Fischer C; Nassisi M; Gatignol P; Dorgham K; Daghsen L; Daye P; Cunha P; Kacher R; Hilab R; Hurmic H; Lamazière A; Lamy JC; Welter ML; Chupin M; Mangin JF; Lane R; Gaymard B; Pouget P; Audo I; Brice A; Tezenas du Montcel S; Durr A
    Neurology; 2024 Sep; 103(5):e209749. PubMed ID: 39133883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy.
    Lirng JF; Wang PS; Chen HC; Soong BW; Guo WY; Wu HM; Chang CY
    PLoS One; 2012; 7(10):e47925. PubMed ID: 23118909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
    Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
    Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
    Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
    Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis.
    Diallo A; Jacobi H; Tezenas du Montcel S; Klockgether T
    J Neurol; 2021 Aug; 268(8):2749-2756. PubMed ID: 32266540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.
    Jacobi H; Bauer P; Giunti P; Labrum R; Sweeney MG; Charles P; Dürr A; Marelli C; Globas C; Linnemann C; Schöls L; Rakowicz M; Rola R; Zdzienicka E; Schmitz-Hübsch T; Fancellu R; Mariotti C; Tomasello C; Baliko L; Melegh B; Filla A; Rinaldi C; van de Warrenburg BP; Verstappen CC; Szymanski S; Berciano J; Infante J; Timmann D; Boesch S; Hering S; Depondt C; Pandolfo M; Kang JS; Ratzka S; Schulz J; Tezenas du Montcel S; Klockgether T
    Neurology; 2011 Sep; 77(11):1035-41. PubMed ID: 21832228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.